BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37806356)

  • 21. Reply by Gattinoni
    Gattinoni L; Coppola S; Cressoni M; Busana M; Rossi S; Chiumello D
    Am J Respir Crit Care Med; 2020 Aug; 202(4):628-630. PubMed ID: 32579036
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum profiling using protein microarrays to identify disease related antigens.
    Sharon D; Snyder M
    Methods Mol Biol; 2014; 1176():169-78. PubMed ID: 25030927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to "Overgeneralization by Anderson et al. and Luz et al. regarding safety of fluorotelomer-base chemistry".
    Anderson JK; Luz AL; Goodrum P
    Regul Toxicol Pharmacol; 2019 Jul; 105():100-101. PubMed ID: 30928331
    [No Abstract]   [Full Text] [Related]  

  • 24. Reply to R.L. Bowen et al, M. Froehner et al, J.L. Leow et al, and C. Brady et al.
    Nead KT; Gaskin G; Chester C; Swisher-McClure S; Dudley JT; Leeper NJ; Shah NH
    J Clin Oncol; 2016 Aug; 34(23):2804-5. PubMed ID: 27298415
    [No Abstract]   [Full Text] [Related]  

  • 25. Reply to K. Quan et Al, S.P. Collins et al, C.R. King et al, s. Arcangeli et al, d.B. Fuller, and D. Vordermark.
    D'Amico AV
    J Clin Oncol; 2014 Oct; 32(30):3457. PubMed ID: 25185103
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply to K. Quan et al, S.p. Collins et al, C.R. King et al, S. Arcangeli et Al, D.B. Fuller, and D. Vordermark.
    Yu JB; Cramer LD; Herrin J; Soulos PR; Potosky AL; Gross CP
    J Clin Oncol; 2014 Oct; 32(30):3456-7. PubMed ID: 25185090
    [No Abstract]   [Full Text] [Related]  

  • 27. Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al.
    Barrington SF; Mikhaeel NG; Kostakoglu L; Meignan M; Hutchings M; Müeller S; Schwartz LH; Zucca E; Fisher RI; Trotman J; Hoekstra OS; Hicks RJ; O'Doherty MJ; Hustinx R; Biggi A; Cavalli F; Lister TA; Cheson BD
    J Clin Oncol; 2015 Apr; 33(10):1221-3. PubMed ID: 25691678
    [No Abstract]   [Full Text] [Related]  

  • 28. Reply to E.L. Pollom et al, N. Ohri et al, A. Fiorentino et al, D.R. Wahl et al, N. Kim et al, J. Boda-Heggemann et al, S. Rana et al, N. Sanuki et al, J.R. Olsen et al, G.L. Smith et al, and A. Shinde et al.
    Rajyaguru DJ; Borgert AJ; Halfdanarson TR; Truty MJ; Kurup AN; Go RS
    J Clin Oncol; 2018 Aug; 36(24):2567-2569. PubMed ID: 29945519
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply to I.F. Tannock, P. Isaacsson Velho et al, R.Z. Szmulewitz et al, M. Tiako Meyo et al, and F.J.S.H. Woei-A-Jin et al.
    Kolesar JM; Liu G
    J Clin Oncol; 2018 Oct; 36(30):3065-3066. PubMed ID: 30188791
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply to Delanghe et al, Boudin et al, and Focosi et al.
    Zhao J; Xing M; Wang PG
    Clin Infect Dis; 2021 Jun; 72(11):e920. PubMed ID: 32986816
    [No Abstract]   [Full Text] [Related]  

  • 31. Reply to Cottin
    Raghu G; Richeldi L; Thomson CC; Remy-Jardin M; Wilson KC
    Am J Respir Crit Care Med; 2023 Jun; 207(11):1542-1543. PubMed ID: 37130124
    [No Abstract]   [Full Text] [Related]  

  • 32. The atomic approach to the Anderson model for the finite U case: application to a quantum dot.
    Lobo T; Figueira MS; Foglio ME
    Nanotechnology; 2010 Jul; 21(27):274007. PubMed ID: 20571194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In reply to the letter to the editor 'in Reply to Gandaglia et al.' by De Bari et al.
    Gandaglia G; Karakiewicz PI; Briganti A; Menon M; Sun M; Abdollah F
    Ann Oncol; 2014 Sep; 25(9):1862-1863. PubMed ID: 24914042
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply to M. Kazi et al, O. Sütcüoğlu et al, and J. Socha et al.
    Aref A; Abdalla A
    J Clin Oncol; 2023 Jan; 41(2):418-419. PubMed ID: 36126245
    [No Abstract]   [Full Text] [Related]  

  • 35. Reply to E. Younger et al, V. Sharma et al, and M. Uchihara et al.
    Grünwald V; Liu X; Schuler M; Bauer S
    J Clin Oncol; 2021 Mar; 39(7):864-865. PubMed ID: 33439687
    [No Abstract]   [Full Text] [Related]  

  • 36. Reply to J. Beyer, T. Tandstad et al, S. Gillessen et al, J. Oldenburg et al, and L.C. Pagliaro et al.
    Vaughn DJ
    J Clin Oncol; 2015 Jul; 33(20):2324-5. PubMed ID: 26033814
    [No Abstract]   [Full Text] [Related]  

  • 37. Violent video game effects remain a societal concern: Reply to Hilgard, Engelhardt, and Rouder (2017).
    Kepes S; Bushman BJ; Anderson CA
    Psychol Bull; 2017 Jul; 143(7):775-782. PubMed ID: 28639811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Getting rid of blinkers: the case of mirror self-recognition in horses (Equus caballus).
    Scopa C; Maglieri V; Baragli P; Palagi E
    Anim Cogn; 2022 Aug; 25(4):711-716. PubMed ID: 35704243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reply: A reply to Tarone et al., Campobasso and Introna, and Michaud et al.
    Wells JD
    J Med Entomol; 2014 Sep; 51(5):907. PubMed ID: 25276916
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply to Soman et al, Alffenaar et al, Metcalfe et al, and Raoult.
    Cegielski JP; Chen MP; Tupasi TE; Leimane V; Volchenkov GV;
    Clin Infect Dis; 2015 Mar; 60(6):971-3. PubMed ID: 25527654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.